4.3 Article

Biocompatibility of intraocular lens power adjustment using a femtosecond laser in a rabbit model

期刊

JOURNAL OF CATARACT AND REFRACTIVE SURGERY
卷 43, 期 8, 页码 1100-1106

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.jcrs.2017.05.040

关键词

-

资金

  1. Research to Prevent Blindness, Inc., New York, New York
  2. Perfect Lens LLC, Irvine, California, USA

向作者/读者索取更多资源

Purpose: To evaluate the biocompatibility (uveal and capsular) of intraocular lens (IOL) power adjustment by a femtosecond laser obtained through increased hydrophilicity of targeted areas within the optic, creating the ability to build a refractive-index shaping lens within an existing IOL. Setting: John A. Moran Eye Center, University of Utah, Salt Lake City, Utah, USA. Design: Experimental study. Methods: Six rabbits had phacoemulsification with bilateral implantation of a commercially available hydrophobic acrylic IOL. The postoperative power adjustment was performed 2 weeks after implantation in 1 eye of each rabbit. The animals were followed clinically for an additional 2 weeks and then killed humanely. Their globes were enucleated and bisected coronally just anterior to the equator for gross examination from the Miyake-Apple view to assess capsular bag opacification. After IOL explantation for power measurements, the globes were sectioned and processed for standard histopathology. Results: Slitlamp examinations performed after the laser treatments showed the formation of small gas bubbles behind the lenses that disappeared within a few hours. No postoperative inflammation or toxicity was observed in the treated.eyes, and postoperative outcomes and histopathological examination results were similar to those in untreated eyes. The, power measurements showed that the change in power obtained was consistent and within +/- 0.1 diopter of the target. Conclusions: Consistent and precise power changes can be induced in the optic of commercially available IOLs in vivo by using a femtosecond laser to create a refractive-index shaping lens. The laser treatment of the IOLs was biocompatible. (C) 2017 ASCRS and ESCRS

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据